Flavokawain B

Flavokawain B

SCHEMBL25209926

COc1cc(O)c(C(=O)C=Cc2ccccc2)c(OC)c1.COc1cccc(-c2cc(=O)c3ccc(OC)cc3o2)c1

nearest known ligand 0.63

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP3A4 P08684 6/20 0.63
▸ MAPT P10636 6/20 0.63
▸ KMT2A Q03164 6/20 0.63
▸ TP53 P04637 4/20 0.63
▸ HSD17B10 Q99714 3/20 0.63
▸ ATM Q13315 1/20 0.63
▸ ABCG2 Q9UNQ0 5/20 0.61
▸ KDM4E B2RXH2 5/20 0.58
▸ HPGD P15428 4/20 0.58
▸ MAPK1 P28482 3/20 0.58
▸ ALDH1A1 P00352 3/20 0.58
▸ USP2 O75604 2/20 0.58
▸ RECQL P46063 1/20 0.58
▸ SMN1; SMN2 Q16637 1/20 0.58
▸ NQO1 P15559 1/20 0.54
▸ CYP2C9 P11712 3/20 0.53
▸ CYP2C19 P33261 3/20 0.53
▸ CYP19A1 P11511 2/20 0.53
▸ MAOA P21397 2/20 0.53
▸ MAOB P27338 2/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Flavokawain B SCHEMBL25195789 0.83 MAPT (0.66) CYP3A4MAPTKMT2ATP53HSD17B10
Flavokawain B SCHEMBL25185055 0.79 MAPT (1.00) CYP3A4MAPTKMT2ATP53HSD17B10
Flavokawain B SCHEMBL29439356 0.79 MAPT (1.00) CYP3A4MAPTKMT2ATP53HSD17B10
Flavokawain B SCHEMBL30382640 0.79 MAPT (1.00) CYP3A4MAPTKMT2ATP53HSD17B10
Flavokawain B SCHEMBL1938260 0.79 MAPT (1.00) CYP3A4MAPTKMT2ATP53HSD17B10
Flavokawain B SCHEMBL1675987 0.79 MAPT (1.00) CYP3A4MAPTKMT2ATP53HSD17B10
Flavokawain B SCHEMBL25265211 0.78 MAPT (0.97) CYP3A4MAPTKMT2ATP53HSD17B10
Flavokawain B SCHEMBL30384635 0.78 MAPT (0.97) CYP3A4MAPTKMT2ATP53HSD17B10
Flavokawain B SCHEMBL25193713 0.78 MAPT (0.97) CYP3A4MAPTKMT2ATP53HSD17B10
SCHEMBL25192230 0.77 MAPT (0.86) CYP3A4MAPTKMT2ATP53HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230190679-A1 COMPOSITIONS AND METHODS FOR TREATING BLEEDING AND BLEEDING DISORDERS YewSavin, Inc. (US) 2023-06-22 — — US disclosed
WO-2023086388-A1 COMPOSITIONS AND METHODS FOR TREATING BLEEDING AND BLEEDING DISORDERS YewSavin, Inc. (US) 2023-05-19 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230190679-A1 COMPOSITIONS AND METHODS FOR TREATING BLEEDING AND BLEEDING DISORDERS SERPINC1, SERPINE1, SERPINH1 CYP3A4 1589/4885MAPT 3512/4885KMT2A 3188/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback